Mycotoxins: Emerging toxic mechanisms, and unanswered research questions

Qinghua Wu1, Li You2, Wenda Wu3

  • 1College of Life Science, Yangtze University, Jingzhou, 434025, China; Department of Chemistry, Faculty of Science, University of Hradec Králové, 50003, Hradec Králové, Czech Republic.

Insights

Mycotoxins may cause neurodegenerative diseases (ND) through unknown mechanisms, potentially involving the brain-gut axis and immune evasion. Further research is needed to understand these complex toxicological pathways.

Area of Science:

  • Toxicology
  • Neuroscience
  • Immunology

Background:

  • Mycotoxins are emerging as potential inducers of human neurodegenerative diseases (ND).
  • The precise molecular mechanisms and involvement of the brain-gut axis remain largely unelucidated.
  • Recent findings suggest immune evasion strategies in certain mycotoxins, like trichothecenes, potentially involving hypoxia.

Purpose of the Study:

  • To address key scientific questions regarding the toxic mechanisms of mycotoxins.
  • To explore the link between mycotoxins and neurodegeneration, including molecular pathways and brain-gut axis involvement.
  • To investigate the potential for immune evasion mechanisms in mycotoxins beyond trichothecenes, such as aflatoxins.

Main Methods:

  • Discussion of critical research questions in mycotoxin toxicology.
  • Focus on signaling pathways, immune modulation (stimulatory vs. suppressive effects), and the interplay of autophagy and apoptosis.
  • Exploration of emerging topics like mycotoxins and aging, cytoskeleton, and immunotoxicity.

Main Results:

  • Identified critical knowledge gaps in understanding mycotoxin-induced toxicity.
  • Highlighted the need for research into mycotoxin-induced neurodegeneration and associated molecular mechanisms.
  • Emphasized the importance of investigating immune evasion and related processes in mycotoxin toxicity.

Conclusions:

  • Mycotoxin toxicity presents complex challenges requiring further investigation into molecular mechanisms.
  • Understanding the role of the brain-gut axis and immune evasion is crucial for assessing mycotoxin risks.
  • This work highlights key areas for future research and encourages submissions to a special issue on mycotoxins and bacterial toxins.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.8K
Fungal Phylum Basidiomycota01:26

Fungal Phylum Basidiomycota

Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
156
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K